par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • September 3rd, 2019 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Aridis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
ARIDIS PHARMACEUTICALS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIESAridis Pharmaceuticals, Inc. • September 3rd, 2019 • Pharmaceutical preparations • New York
INDENTURE , dated as of [ · ], among Aridis Pharmaceuticals, Inc. , a Delaware corporation (the “Company”), and [ TRUSTEE ], as trustee (the “Trustee”):
